People · Operator
Named in public records as an officer, director or promoter · active 2018–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rodeo Therapeutics Corp | — | Biotechnology | Series A | $14.3M | $323.6M | 2018 |
| Orion Biotechnology Canada Ltd. | — | Biotechnology | Series A | $11.2M | $3.9M | 2024 |
Katie Hewitt at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Katie Hewitt on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Asish Xavier | 1 | 18 |
| Steve Gillis | 1 | 13 |
| Thong Le | 1 | 12 |
| Joel Marcus | 1 | 9 |
| James Sullivan | 1 | 7 |
| Lindsay Rayle | 1 | 7 |
| David Schubert | 1 | 6 |
| Ian Howes | 1 | 5 |
| Kendall Mohler | 1 | 5 |
| Praveen Tyle | 1 | 5 |
| Margarita Chavez | 1 | 4 |
| Suzanne Rettenmier | 1 | 3 |
| Jason Burke | 1 | 2 |
| Theresa Firestone | 1 | 2 |
| Bradford Smith | 1 | 2 |
| Tadataka Yamada | 1 | 2 |
| Lonnel Coats | 1 | 2 |
| Anatolii Sheila Klepatskyi | 1 | 1 |
| Mark Sheila Groper | 1 | 1 |
| Sanford Markowitz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.